Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade C 3.41 -6.06% -0.22
AYTU closed down 6.06 percent on Friday, January 19, 2018, on 72 percent of normal volume.
1 Watcher
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Very Strong N/A Up Up
See historical AYTU trend table...

Date Alert Name Type % Chg
Jan 19 Calm After Storm Range Contraction 0.00%
Jan 19 Upper Bollinger Band Walk Strength 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 18 Calm After Storm Range Contraction -6.06%
Jan 18 Upper Bollinger Band Walk Strength -6.06%
Jan 18 Wide Bands Range Expansion -6.06%
Jan 18 Above Upper BB Strength -6.06%
Jan 18 Upper Bollinger Band Touch Strength -6.06%
Jan 17 Stochastic Reached Overbought Strength -10.03%
Jan 17 Upper Bollinger Band Walk Strength -10.03%

Older signals for AYTU ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.82
52 Week Low 2.05
Average Volume 121,771
200-Day Moving Average 0.0
50-Day Moving Average 2.7372
20-Day Moving Average 2.596
10-Day Moving Average 2.93
Average True Range 0.4458
ADX 50.74
+DI 39.2
-DI 10.56
Chandelier Exit (Long, 3 ATRs ) 2.9226
Chandelier Exit (Short, 3 ATRs ) 3.3874
Upper Bollinger Band 3.6326
Lower Bollinger Band 1.5594
Percent B (%b) 0.89
BandWidth 79.861325
MACD Line 0.1935
MACD Signal Line 0.0255
MACD Histogram 0.168
Fundamentals Value
Market Cap 13.71 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.07
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.12
Resistance 3 (R3) 4.11 3.87 4.00
Resistance 2 (R2) 3.87 3.69 3.87 3.96
Resistance 1 (R1) 3.64 3.58 3.52 3.65 3.92
Pivot Point 3.40 3.40 3.34 3.40 3.40
Support 1 (S1) 3.17 3.22 3.05 3.18 2.90
Support 2 (S2) 2.93 3.11 2.93 2.86
Support 3 (S3) 2.70 2.93 2.82
Support 4 (S4) 2.71